BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12836712)

  • 1. Costs and effects of enalapril therapy in patients with symptomatic heart failure: an economic analysis of the Studies of Left Ventricular Dysfunction (SOLVD) Treatment Trial.
    Glick H; Cook J; Kinosian B; Pitt B; Bourassa MG; Pouleur H; Gerth W
    J Card Fail; 1995 Dec; 1(5):371-80. PubMed ID: 12836712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cost effectiveness of ACE inhibition in therapy of chronic heart failure in Switzerland: evaluation based on the SOLVD study].
    Szucs TD; Goedde M; Berger K; Kiowski W
    Schweiz Med Wochenschr; 1997 Jul; 127(29-30):1234-41. PubMed ID: 9333933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost and cardioprotective effects of enalapril in hypertensive patients with left ventricular dysfunction.
    Cook JR; Glick HA; Gerth W; Kinosian B; Kostis JB
    Am J Hypertens; 1998 Dec; 11(12):1433-41. PubMed ID: 9880125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure. A decision analytic analysis of New Zealand data using the published results of the SOLVD Treatment Trial. Studies of Left Ventricular Dysfunction.
    Scott WG; Scott HM
    Pharmacoeconomics; 1996 Feb; 9(2):156-67. PubMed ID: 10160094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost-effectiveness analysis of enalapril maleate in the management of congestive heart failure in Australia.
    Butler JR; Fletcher PJ
    Aust N Z J Med; 1996 Feb; 26(1):89-95. PubMed ID: 8775534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cost-effectiveness analysis of the treatment with enalapril of chronic heart failure in Spain].
    Antoñanzas Villar F; Antón Botella F; Echevarría Echarri L
    Gac Sanit; 1996; 10(54):135-42. PubMed ID: 8991882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure.
    Böhm M; Pogue J; Kindermann I; Pöss J; Koon T; Yusuf S
    Eur J Heart Fail; 2014 Mar; 16(3):325-33. PubMed ID: 24464788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure.
    Paul SD; Kuntz KM; Eagle KA; Weinstein MC
    Arch Intern Med; 1994 May; 154(10):1143-9. PubMed ID: 8185426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study.
    Jong P; Yusuf S; Rousseau MF; Ahn SA; Bangdiwala SI
    Lancet; 2003 May; 361(9372):1843-8. PubMed ID: 12788569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of chronic kidney disease and anemia on hospitalization expense in patients with left ventricular dysfunction.
    Gregory DD; Sarnak MJ; Konstam MA; Pereira B; Salem D
    Am J Cardiol; 2003 Dec; 92(11):1300-5. PubMed ID: 14636907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction.
    Exner DV; Dries DL; Domanski MJ; Cohn JN
    N Engl J Med; 2001 May; 344(18):1351-7. PubMed ID: 11333991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the Studies of Left Ventricular Dysfunction. The SOLVD Investigators.
    Rogers WJ; Johnstone DE; Yusuf S; Weiner DH; Gallagher P; Bittner VA; Ahn S; Schron E; Shumaker SA; Sheffield LT
    J Am Coll Cardiol; 1994 Feb; 23(2):393-400. PubMed ID: 8294693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited.
    Parker AB; Yusuf S; Naylor CD
    Am Heart J; 2002 Dec; 144(6):941-7. PubMed ID: 12486418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.
    Konstam MA; Rousseau MF; Kronenberg MW; Udelson JE; Melin J; Stewart D; Dolan N; Edens TR; Ahn S; Kinan D
    Circulation; 1992 Aug; 86(2):431-8. PubMed ID: 1638712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators.
    Konstam V; Salem D; Pouleur H; Kostis J; Gorkin L; Shumaker S; Mottard I; Woods P; Konstam MA; Yusuf S
    Am J Cardiol; 1996 Oct; 78(8):890-5. PubMed ID: 8888661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).
    Knight EL; Glynn RJ; McIntyre KM; Mogun H; Avorn J
    Am Heart J; 1999 Nov; 138(5 Pt 1):849-55. PubMed ID: 10539815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).
    Packer M; Califf RM; Konstam MA; Krum H; McMurray JJ; Rouleau JL; Swedberg K
    Circulation; 2002 Aug; 106(8):920-6. PubMed ID: 12186794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.
    Benedict CR; Shelton B; Johnstone DE; Francis G; Greenberg B; Konstam M; Probstfield JL; Yusuf S
    Circulation; 1996 Aug; 94(4):690-7. PubMed ID: 8772689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
    Reed SD; Friedman JY; Velazquez EJ; Gnanasakthy A; Califf RM; Schulman KA
    Am Heart J; 2004 Jul; 148(1):122-8. PubMed ID: 15215801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.